Lung cancer (non-small-cell, advanced or metastatic maintenance treatment) - erlotinib (monotherapy): Roche - initial scrutiny letter
|
Lung cancer (non-small-cell, advanced or metastatic maintenance treatment) - erlotinib (monotherapy): Roche - initial scrutiny letter
16 May 2011 (45.42 Kb 13 sec) |
This page was last updated: 13 May 2011